Indivior PLC Notice of Results (5504N)
21 January 2019 - 6:00PM
UK Regulatory
TIDMINDV
RNS Number : 5504N
Indivior PLC
21 January 2019
Indivior to Announce and Present FY 2018 Results on February
14th
Slough, UK, and Richmond, VA, January 21, 2019 - Indivior PLC
(LON: INDV) today announced that it will release its FY 2018
results on February 14th at 7:00 a.m. London time (2:00 a.m. U.S.
Eastern). The results will be available via the London Stock
Exchange's Regulatory News Service (RNS) and on the "Investors"
section of the company's website at www.indivior.com.
Key members of Indivior's leadership team led by Shaun Thaxter,
Chief Executive Officer, will present the FY 2018 results and
address questions from qualified analysts and investors at 11:30
a.m. London time (6:30 a.m. U.S. Eastern) on February 14th. The
presentation will take place at The London Stock Exchange ("LSE")
in Avenues 1-3, 10 Paternoster Square, London EC4M 7LS.
An RSVP at least 48 hours in advance is required if you plan to
attend the presentation in person. Please RSVP to Jason Thompson,
Vice President, Investor Relations at jason.thompson@indivior.com.
Given the LSE's strict security procedures, government issued
picture identification will be required for entry. Those not on the
LSE's security list 48-hours ahead of the event time will not be
permitted entry to the presentation.
Remote Access to the Live Webcast for Indivior's FY 2018 Results
Presentation
A live webcast of the FY 2018 results presentation will also be
available. The webcast event and materials can be accessed on the
"Investors" section of the company's website at www.indivior.com
shortly before the event begins on February 14th at 11:30 a.m.
London time (6:30 a.m. U.S. EDT). The webcast link is
https://edge.media-server.com/m6/p/at8xatmw. Participants also may
access the FY 2018 results presentation telephonically: US
participants 1-877-870-9135; international participants
44(0)2071-928338. Please reference event passcode number 2271449. A
replay of the presentation will be available at
www.indivior.com.
About Indivior
Indivior is a global specialty pharmaceutical company with a
20-year legacy of leadership in patient advocacy and health policy
while providing education on evidence-based treatment models that
have revolutionized modern addiction treatment. The name is the
fusion of the words individual and endeavor, and the tagline "Focus
on you" makes the Company's commitment clear. Indivior is dedicated
to transforming addiction from a global human crisis to a
recognized and treated chronic disease. Building on its global
portfolio of opioid dependence treatments, Indivior has a strong
pipeline of product candidates designed to both expand on its
heritage in this category and address other chronic conditions and
co-occurring disorders of addiction, including alcohol use disorder
and schizophrenia. Headquartered in the United States in Richmond,
VA, Indivior employs more than 900 individuals globally and its
portfolio of products is available in over 40 countries worldwide.
Visit www.indivior.com to learn more.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-423-8916 or jason.thompson@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOREASFPFDDNEFF
(END) Dow Jones Newswires
January 21, 2019 02:00 ET (07:00 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2023 to Apr 2024